Fortis Healthcare Limited (NSE:FORTIS)
664.55
+14.60 (2.25%)
Apr 17, 2025, 3:30 PM IST
Fortis Healthcare Revenue
Fortis Healthcare had revenue of 19.28B INR in the quarter ending December 31, 2024, with 14.80% growth. This brings the company's revenue in the last twelve months to 75.61B, up 12.03% year-over-year. In the fiscal year ending March 31, 2024, Fortis Healthcare had annual revenue of 68.93B with 9.45% growth.
Revenue (ttm)
75.61B
Revenue Growth
+12.03%
P/S Ratio
6.64
Revenue / Employee
6.26M
Employees
12,088
Market Cap
501.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 68.93B | 5.95B | 9.45% |
Mar 31, 2023 | 62.98B | 5.80B | 10.14% |
Mar 31, 2022 | 57.18B | 16.87B | 41.87% |
Mar 31, 2021 | 40.30B | -6.02B | -13.00% |
Mar 31, 2020 | 46.32B | 1.63B | 3.65% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Fortis Healthcare News
- 15 days ago - Fortis Healthcare in focus: Subsidiary receives Rs 76.19 crore income tax demand for FY2019 - Business Upturn
- 16 days ago - Fortis Healthcare secures full ownership of ‘Fortis’ trademark for Rs 200 crore after Delhi High Court approval - Business Upturn
- 25 days ago - Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025] - Business Upturn
- 4 weeks ago - Fortis Healthcare receives injunction order related to Shrimann Hospital acquisition - Business Upturn
- 2 months ago - Fortis Healthcare subsidiary acquires Shrimann Superspecialty Hospital in Jalandhar for Rs 461.9 crore - Business Upturn
- 2 months ago - What to buy and sell today (February 10): M&M, SBI, Fortis among top picks, LIC & Ola Electric in focus - Business Upturn
- 2 months ago - Nomura on Fortis Health: Buy call, target at Rs 700, sees 8% upside on strong hospital revenue - Business Upturn
- 2 months ago - Fortis Healthcare Q3 FY25 results: Net profit jumps 89.4% YoY to Rs 254.3 Crore, revenue climbs 14.8% YoY - Business Upturn